INDEX 



597 



Lecithin, function of, 289 



, pure, hardly obtainable, 290 



in suprarenal capsules, 280 

 Lecithin-carbohydrate, 286 

 Leucocytes, glycogen content, cause of 



increase, 418 

 Levulose, administration of, effect, 



430 

 , experimental results, 417, 418, 



419 



, inhibits action of invertin, 419 

 " Leydig's between-cells/' 392 

 Leydig cells, 394 



, relationship to genital hormone, 



398 

 Lipoid granules in cells of suprarenal 



cortex, 272 

 substances, 21 



in suprarenal capsules, 292, 



293 



Lipoids, suprarenal, 279, 287 

 Liver, accumulation of glycogen in, 



427, 428 

 - , deposition of glycogen in, after 



extirpation of pancreas, how 



effected, 430 

 , effect on destruction of adrenalin, 



257 

 , formation of glycogen in, 216 



- of sugar in, inhibited by pan- 

 creas, 430 



, how controlled, 428, 429 

 urea by, antitoxic function, 9 

 , glycogen in, reduced after extir- 

 pation of pancreas, 418 

 Lutein cells, origin of, 401 



tabloids, therapeutic use of, 405 

 Lymph, excretion from thoracic duct, 



promoted by adrenalin, 213 

 glands, cells of thymus gland not 



identical with those of, 112 

 Lymph-vessels, passage of thyroid 



secretion into, 28 

 Lymphagoga, suppression of adrenalin- 



glycosuria by, 221 

 Lymphagogues, 443, 444 

 , blood from subject of kidney dis- 

 ease acting as, 444 

 Lymphatic ducts, ligature of, 221 

 Lymphatics, peritoneal, action of 

 adrenalin on, 213 



MAMMALS, blood-circulation in supra- 

 renals of, 300, 301 



, cortex and medulla of suprarenal 

 capsules amalgamated in, 130 



, innervation of bladder, differences 

 in, 205, 206 



, suprarenal bodies in, develop- 

 ment, 133 



Mammary glands, 355, 360 



, development of, 372, 375 



Marchand's accessory suprarenals, 

 tumours of female genitals 

 derived from, 270 



" Masculinity,-'' 362 



Menstruation, connection of ovulation 



with, 403, 406 



, disordered, in acromegaly, 331, 337 

 , origin of, 406 

 , relationship of ovarv to, 381 

 Mental changes following thyroid- 



ectomy, 65 

 Mercapturic acid, affinity of gly- 



curonic acid for, 9 



Metabolic changes in hypothyrosis, SS 

 , how influenced by thyroid 

 extract, 88 

 Metabolism, action of adrenalin on, 



214, 215 

 , effects of pituitary extract on, 327 



, thyroid extract on, 91 

 , end-products of, function, 15 

 in endemic cretinism, 89 

 in Graves's disease greatly in- 

 creased, 98 

 in myxcedema, 88, 89 

 in pancreatic diabetes, 415 

 , processes of, changes following 



thyroidectomy, 67 

 , glands accelerating, 70 



- retarding, 70 



Methylaminoketone, action on blood- 

 pressure, 213 

 Meyer's method, effects of adrenalin 



determined by, 199 

 Mice, parathyroid tetany in, 41 

 Milk diet in acute tetany, 107 

 , secretion of, 372, 375 

 Mongolism, diagnosis from sporadic 



myxcedema, 78 

 Monoamidomonophosphatide cephalin, 



292 

 Mors thymia, sec Status thymico- 



lyin'phaticiis, sudden death in 

 Mountain climbing, effect on upper 



extremities, 14 



Muscarin and adrenalin, action com- 

 pared, 258, 259 



Muscles, action of adrenalin on, 228, 

 229 



and apocodein on, com- 

 pared, 228 

 - 3 chemical processes, relation of 



formation of adrenalin to, 296 

 , effect of pituitary extract on, 320 

 , glycogen in, disappearing after 



extirpation of pancreas, 418 

 - 3 glycolytic ferment in, 426 

 , involuntary nerve supply to, 191 

 , toxicity of, following extirpation 



of suprarenals, 156 

 3 unstriated, action of adrenalin on, 



229 

 , and sympathetic nervous 



system, 229 



, vascular, see Arteries, muscles of 



Muscular exertion, effect on glyco- 



suria in pajicreatic diabetes, 417 



weakness following suprarenal 



suppression, 156 



